首页 > 最新文献

Journal of the Chinese Medical Association : JCMA最新文献

英文 中文
Association of periodontal disease with the prognosis of chronic kidney disease: A meta-analysis. 牙周病与慢性肾病预后的关系:荟萃分析
Pub Date : 2024-10-11 DOI: 10.1097/JCMA.0000000000001178
Tao He, Xue Li, Chun-Juan Liao, Xing-Yu Feng, Xiang-Yu Guo

Background: To assess the association between periodontal disease (PD) and the prognosis of chronic kidney disease (CKD).

Methods: A systematic literature search was conducted using PubMed, Embase, and Cochrane Library to identify eligible cohort studies until April 2023. Relative risk (RR) with a 95% confidence interval (CI) was used to evaluate the strength of the relationship between PD and CKD prognosis using the random-effects model.

Results: 10 cohort studies involving 10,144 patients with CKD were selected for the meta-analysis. The summary results indicated that PD was associated with an increased risk of all-cause mortality in patients with CKD (RR:1.32; 95%CI:1.10-1.59; 𝑝 = 0.003). Although no association was observed between PD and the risk of cardiac death in patients with CKD (𝑝 = 0.180), while sensitivity analysis revealed PD may be associated with the risk of cardiac death (RR:1.31; 95%CI:1.05-1.64; 𝑝 = 0.017). In addition, subgroup analyses revealed that the strength of the association of PD with the risks of all-cause mortality and cardiac death varies when stratified by region, male proportion, comparison, CKD stage, and adjusted level.

Conclusion: Herein, PD might exert a harmful effect on the subsequent risks of all-cause mortality and cardiac death in patients with CKD.

背景:评估牙周病(PD)与慢性肾脏病(CKD)预后的关系:评估牙周病(PD)与慢性肾脏病(CKD)预后之间的关系:方法:使用PubMed、Embase和Cochrane图书馆进行了系统性文献检索,以确定2023年4月之前符合条件的队列研究。采用随机效应模型,以95%置信区间(CI)的相对风险(RR)来评估PD与CKD预后之间关系的强度:荟萃分析选取了涉及 10,144 名 CKD 患者的 10 项队列研究。汇总结果表明,PD 与 CKD 患者全因死亡风险增加有关(RR:1.32;95%CI:1.10-1.59;𝑝 = 0.003)。虽然未观察到PD与CKD患者心脏死亡风险之间存在关联(𝑝 = 0.180),但敏感性分析显示PD可能与心脏死亡风险有关(RR:1.31; 95%CI:1.05-1.64; 𝑝 = 0.017)。此外,亚组分析显示,当按地区、男性比例、比较、CKD分期和调整后水平进行分层时,PD与全因死亡和心源性死亡风险的关联强度有所不同:结论:PD可能会对CKD患者随后的全因死亡和心脏死亡风险产生有害影响。
{"title":"Association of periodontal disease with the prognosis of chronic kidney disease: A meta-analysis.","authors":"Tao He, Xue Li, Chun-Juan Liao, Xing-Yu Feng, Xiang-Yu Guo","doi":"10.1097/JCMA.0000000000001178","DOIUrl":"https://doi.org/10.1097/JCMA.0000000000001178","url":null,"abstract":"<p><strong>Background: </strong>To assess the association between periodontal disease (PD) and the prognosis of chronic kidney disease (CKD).</p><p><strong>Methods: </strong>A systematic literature search was conducted using PubMed, Embase, and Cochrane Library to identify eligible cohort studies until April 2023. Relative risk (RR) with a 95% confidence interval (CI) was used to evaluate the strength of the relationship between PD and CKD prognosis using the random-effects model.</p><p><strong>Results: </strong>10 cohort studies involving 10,144 patients with CKD were selected for the meta-analysis. The summary results indicated that PD was associated with an increased risk of all-cause mortality in patients with CKD (RR:1.32; 95%CI:1.10-1.59; 𝑝 = 0.003). Although no association was observed between PD and the risk of cardiac death in patients with CKD (𝑝 = 0.180), while sensitivity analysis revealed PD may be associated with the risk of cardiac death (RR:1.31; 95%CI:1.05-1.64; 𝑝 = 0.017). In addition, subgroup analyses revealed that the strength of the association of PD with the risks of all-cause mortality and cardiac death varies when stratified by region, male proportion, comparison, CKD stage, and adjusted level.</p><p><strong>Conclusion: </strong>Herein, PD might exert a harmful effect on the subsequent risks of all-cause mortality and cardiac death in patients with CKD.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142407330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High dose chemotherapy with autologous stem cell rescue in children and young adults with high-risk Ewing sarcoma: A single institute experience in Taiwan. 高风险尤文肉瘤儿童和青少年患者的大剂量化疗与自体干细胞救治:台湾一家研究所的经验。
Pub Date : 2024-10-11 DOI: 10.1097/JCMA.0000000000001179
Chih-Ying Lee, Hsiu-Ju Yen, Ming-Hsin Hou, Giun-Yi Hung, Cheng-Yin Ho, Ting-Yen Yu, Po-Kuei Wu, Chao-Ming Chen, Chueh-Chuan Yen, Cheng-Ying Shiau, Paul Chih-Hsueh Chen, Hung-Ta Hondar Wu, Ching-Lan Wu, Wei-Ming Chen

Background: A combination treatment of surgery, chemotherapy, and radiotherapy can improve the survivals of pediatric patients with Ewing sarcoma (ES). However, prognosis remains poor for patients with metastatic disease at diagnosis or recurrence. Other high-risk (HR) features include large tumor burden, tumors of the axial skeleton and poor histologic response. Several studies have documented high dose chemotherapy with autologous stem cell rescue (HDC-ASCR) to be effective in such patients. In this retrospective study, we present the results of HDC-ASCR for high-risk Ewing sarcoma in children and young adults in a single institute.

Methods: From March 2004 to March 2021, patients with ES, Ewing-like sarcoma, or round cell sarcoma received HDC-ASCR as part of treatment were included. The patients' characteristics, disease status, stem cell dose, engraftment status, post-transplant complications, and outcomes were analyzed.

Results: Twenty patients receiving HDC-ASCR at complete response (n = 6), partial response (n = 13), and stable disease (n = 1) were enrolled. The male to female ratio was 11:9. Median age at diagnosis and transplant was 15.6 years old (range: 3.3-28.9) and 16.2 (range: 4.2-29.9), respectively. The conditioning regimens included ifosfamide-based in two and melphalan-based in 19. All patients achieved successful engraftment without tansplant-related mortality. The 5-year progression-free and overall survival (OS) rate were 35% and 54.5%, respectively. The causes of death (n = 8) were all contributed to disease progression. Patients in the complete response group or with localized HRES exhibited a higher 5-year OS (p = 0.047 and 0.05, respectively). Compared to the historical cohort without HDC-ASCR as part of primary treatment, the current cohort had a significantly better 5-year OS (p = 0.018).

Conclusion: HDC-ASCR seems promising as an alternative treatment for HRES in improving OS in this retrospective study with limited case number.

背景:手术、化疗和放疗的综合治疗可提高儿童尤文肉瘤(ES)患者的存活率。然而,确诊时有转移性疾病或复发的患者预后仍然很差。其他高危(HR)特征包括肿瘤负荷大、肿瘤位于轴状骨骼和组织学反应差。多项研究表明,大剂量化疗联合自体干细胞救治(HDC-ASCR)对此类患者有效。在这项回顾性研究中,我们介绍了一家研究所采用HDC-ASCR治疗高危儿童和年轻成人尤文肉瘤的结果:方法:纳入 2004 年 3 月至 2021 年 3 月期间接受 HDC-ASCR 治疗的 ES、尤文样肉瘤或圆形细胞肉瘤患者。分析了患者的特征、疾病状态、干细胞剂量、移植状态、移植后并发症和预后:20名患者在完全反应(6人)、部分反应(13人)和病情稳定(1人)时接受了HDC-ASCR治疗。男女比例为 11:9。诊断和移植时的中位年龄分别为 15.6 岁(范围:3.3-28.9)和 16.2 岁(范围:4.2-29.9)。2名患者采用了伊福酰胺治疗方案,19名患者采用了美法仑治疗方案。所有患者都成功实现了移植,且无坦杉相关死亡率。5年无进展生存率和总生存率(OS)分别为35%和54.5%。死亡原因(8 例)均与疾病进展有关。完全应答组或局部HRES患者的5年生存率较高(P = 0.047和0.05)。与未将HDC-ASCR作为主要治疗手段的历史队列相比,当前队列的5年OS明显更好(p = 0.018):结论:在这项病例数有限的回顾性研究中,HDC-ASCR似乎有望作为HRES的替代治疗方法,改善患者的OS。
{"title":"High dose chemotherapy with autologous stem cell rescue in children and young adults with high-risk Ewing sarcoma: A single institute experience in Taiwan.","authors":"Chih-Ying Lee, Hsiu-Ju Yen, Ming-Hsin Hou, Giun-Yi Hung, Cheng-Yin Ho, Ting-Yen Yu, Po-Kuei Wu, Chao-Ming Chen, Chueh-Chuan Yen, Cheng-Ying Shiau, Paul Chih-Hsueh Chen, Hung-Ta Hondar Wu, Ching-Lan Wu, Wei-Ming Chen","doi":"10.1097/JCMA.0000000000001179","DOIUrl":"https://doi.org/10.1097/JCMA.0000000000001179","url":null,"abstract":"<p><strong>Background: </strong>A combination treatment of surgery, chemotherapy, and radiotherapy can improve the survivals of pediatric patients with Ewing sarcoma (ES). However, prognosis remains poor for patients with metastatic disease at diagnosis or recurrence. Other high-risk (HR) features include large tumor burden, tumors of the axial skeleton and poor histologic response. Several studies have documented high dose chemotherapy with autologous stem cell rescue (HDC-ASCR) to be effective in such patients. In this retrospective study, we present the results of HDC-ASCR for high-risk Ewing sarcoma in children and young adults in a single institute.</p><p><strong>Methods: </strong>From March 2004 to March 2021, patients with ES, Ewing-like sarcoma, or round cell sarcoma received HDC-ASCR as part of treatment were included. The patients' characteristics, disease status, stem cell dose, engraftment status, post-transplant complications, and outcomes were analyzed.</p><p><strong>Results: </strong>Twenty patients receiving HDC-ASCR at complete response (n = 6), partial response (n = 13), and stable disease (n = 1) were enrolled. The male to female ratio was 11:9. Median age at diagnosis and transplant was 15.6 years old (range: 3.3-28.9) and 16.2 (range: 4.2-29.9), respectively. The conditioning regimens included ifosfamide-based in two and melphalan-based in 19. All patients achieved successful engraftment without tansplant-related mortality. The 5-year progression-free and overall survival (OS) rate were 35% and 54.5%, respectively. The causes of death (n = 8) were all contributed to disease progression. Patients in the complete response group or with localized HRES exhibited a higher 5-year OS (p = 0.047 and 0.05, respectively). Compared to the historical cohort without HDC-ASCR as part of primary treatment, the current cohort had a significantly better 5-year OS (p = 0.018).</p><p><strong>Conclusion: </strong>HDC-ASCR seems promising as an alternative treatment for HRES in improving OS in this retrospective study with limited case number.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142407331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating T-lymphocyte subsets as promising biomarkers for the identification of sepsis-induced acute kidney injury. 循环 T 淋巴细胞亚群是识别脓毒症诱发急性肾损伤的理想生物标志物。
Pub Date : 2024-10-04 DOI: 10.1097/JCMA.0000000000001177
Xue-Ling Guo, Cheng-Xiang Lu, Yan Luo, Ping-Ping Wang, Wen-Song Su, Si-Jiu Yang, Ling-Hui Zhan

Background: This retrospective study investigated whether disturbances in circulating T-lymphocyte subsets could predict the incidence of acute kidney injury (AKI) and in-hospital mortality in patients with sepsis.

Methods: Clinical data from patients with sepsis admitted to the intensive care unit were reviewed. Logistic regression analyses were used to identify independent predictors of in-hospital mortality and the development of AKI.

Results: Of 81 patients with sepsis, 50 developed AKI. Both non-survivors and patients with septic AKI exhibited dramatically higher Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHE) II scores. Non-survivors exhibited more organ damage, with significantly lower levels of peripheral T-lymphocyte subsets, including total circulating lymphocytes, and CD3+, CD3+CD4+, and CD3+CD8+ T-lymphocytes. Patients with septic AKI exhibited fewer total peripheral lymphocytes and fewer CD3+, CD3+CD4+, and CD3+CD8+ T-lymphocytes, with higher serum lactate levels and lower nadir platelet counts. Independent predictors of 30-day hospital mortality included maximum SOFA and APACHE II scores, occurrence of encephalopathy, and peripheral CD3+ and CD3+CD8+ T lymphocyte counts. Moreover, the maximum SOFA score and CD3+ and CD3+CD8+ T-lymphocyte counts demonstrated good predictive power for AKI in receiver operating characteristic curve (ROC) analyses, with an area under the ROC curve of 0.810 (95% confidence interval [CI] 0.712-0.908) for SOFA score, 0.849 (95% CI 0.764-0.934) for CD3+ T-lymphocytes, and 0.856 (95% CI 0.772-0.941) for CD3+CD8+ T-lymphocytes.

Conclusion: Patients with sepsis-induced AKI experienced T lymphopenia and increased in-hospital mortality. Higher maximum SOFA scores and reduced peripheral CD3+ and CD3+CD8+ T-lymphocyte levels were associated with in-hospital mortality and the development of AKI in patients with sepsis.

背景:这项回顾性研究探讨了循环 T 淋巴细胞亚群的紊乱是否能预测脓毒症患者急性肾损伤(AKI)的发生率和院内死亡率:研究回顾了重症监护室收治的败血症患者的临床数据。方法:研究人员回顾了重症监护室收治的脓毒症患者的临床数据,并使用逻辑回归分析确定了院内死亡率和急性肾损伤发生的独立预测因素:81名脓毒症患者中有50人出现了AKI。非存活患者和脓毒症 AKI 患者的序贯器官衰竭评估(SOFA)和急性生理学与慢性健康评估(APACHE)II 评分均显著升高。非幸存者表现出更多的器官损伤,外周T淋巴细胞亚群(包括循环淋巴细胞总数、CD3+、CD3+CD4+和CD3+CD8+T淋巴细胞)水平明显降低。脓毒症 AKI 患者的外周淋巴细胞总数较少,CD3+、CD3+CD4+ 和 CD3+CD8+ T 淋巴细胞较少,血清乳酸水平较高,最低血小板计数较低。30 天住院死亡率的独立预测因素包括 SOFA 和 APACHE II 最高评分、脑病发生率以及外周 CD3+ 和 CD3+CD8+ T 淋巴细胞计数。此外,在接收器操作特征曲线(ROC)分析中,SOFA 最大评分和 CD3+ 及 CD3+CD8+ T 淋巴细胞计数对 AKI 具有良好的预测能力,ROC 曲线下面积为 0.SOFA评分的ROC曲线下面积为0.810(95%置信区间[CI] 0.712-0.908),CD3+ T淋巴细胞的ROC曲线下面积为0.849(95%置信区间[CI] 0.764-0.934),CD3+CD8+ T淋巴细胞的ROC曲线下面积为0.856(95%置信区间[CI] 0.772-0.941):结论:脓毒症诱发的 AKI 患者会出现 T 淋巴细胞减少,并增加院内死亡率。脓毒症患者较高的SOFA最高评分和较低的外周CD3+和CD3+CD8+ T淋巴细胞水平与院内死亡率和AKI的发生有关。
{"title":"Circulating T-lymphocyte subsets as promising biomarkers for the identification of sepsis-induced acute kidney injury.","authors":"Xue-Ling Guo, Cheng-Xiang Lu, Yan Luo, Ping-Ping Wang, Wen-Song Su, Si-Jiu Yang, Ling-Hui Zhan","doi":"10.1097/JCMA.0000000000001177","DOIUrl":"https://doi.org/10.1097/JCMA.0000000000001177","url":null,"abstract":"<p><strong>Background: </strong>This retrospective study investigated whether disturbances in circulating T-lymphocyte subsets could predict the incidence of acute kidney injury (AKI) and in-hospital mortality in patients with sepsis.</p><p><strong>Methods: </strong>Clinical data from patients with sepsis admitted to the intensive care unit were reviewed. Logistic regression analyses were used to identify independent predictors of in-hospital mortality and the development of AKI.</p><p><strong>Results: </strong>Of 81 patients with sepsis, 50 developed AKI. Both non-survivors and patients with septic AKI exhibited dramatically higher Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHE) II scores. Non-survivors exhibited more organ damage, with significantly lower levels of peripheral T-lymphocyte subsets, including total circulating lymphocytes, and CD3+, CD3+CD4+, and CD3+CD8+ T-lymphocytes. Patients with septic AKI exhibited fewer total peripheral lymphocytes and fewer CD3+, CD3+CD4+, and CD3+CD8+ T-lymphocytes, with higher serum lactate levels and lower nadir platelet counts. Independent predictors of 30-day hospital mortality included maximum SOFA and APACHE II scores, occurrence of encephalopathy, and peripheral CD3+ and CD3+CD8+ T lymphocyte counts. Moreover, the maximum SOFA score and CD3+ and CD3+CD8+ T-lymphocyte counts demonstrated good predictive power for AKI in receiver operating characteristic curve (ROC) analyses, with an area under the ROC curve of 0.810 (95% confidence interval [CI] 0.712-0.908) for SOFA score, 0.849 (95% CI 0.764-0.934) for CD3+ T-lymphocytes, and 0.856 (95% CI 0.772-0.941) for CD3+CD8+ T-lymphocytes.</p><p><strong>Conclusion: </strong>Patients with sepsis-induced AKI experienced T lymphopenia and increased in-hospital mortality. Higher maximum SOFA scores and reduced peripheral CD3+ and CD3+CD8+ T-lymphocyte levels were associated with in-hospital mortality and the development of AKI in patients with sepsis.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Winners of the 2023 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part VI. 中华医学会台北年会 2023 年度优秀荣誉奖获奖者:第六部分.
Pub Date : 2024-10-01 Epub Date: 2024-08-02 DOI: 10.1097/JCMA.0000000000001140
Peng-Hui Wang, Wen-Hsun Chang
{"title":"Winners of the 2023 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part VI.","authors":"Peng-Hui Wang, Wen-Hsun Chang","doi":"10.1097/JCMA.0000000000001140","DOIUrl":"10.1097/JCMA.0000000000001140","url":null,"abstract":"","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"901-903"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141877030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Winners of the 2023 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part V. 中华医学会台北年会 2023 年度优秀荣誉奖获奖者:第五部分.
Pub Date : 2024-10-01 Epub Date: 2024-08-05 DOI: 10.1097/JCMA.0000000000001139
Chia-Hao Liu, Peng-Hui Wang
{"title":"Winners of the 2023 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part V.","authors":"Chia-Hao Liu, Peng-Hui Wang","doi":"10.1097/JCMA.0000000000001139","DOIUrl":"10.1097/JCMA.0000000000001139","url":null,"abstract":"","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"899-900"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141891442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associated factors of osteoporosis in Chinese patients with rheumatoid arthritis: A systematic review and meta-analysis. 中国类风湿关节炎患者骨质疏松症的相关因素:系统回顾与荟萃分析
Pub Date : 2024-10-01 Epub Date: 2024-08-07 DOI: 10.1097/JCMA.0000000000001144
Zhiming Song, Liangliang Fan, Hongyan Wang, Jun Cao, Zhifei Wen, Yanmin Tao, Xiangeng Zhang

Background: The aim of this systematic review and meta-analysis was to analyze the factors associated of osteoporosis in patients with rheumatoid arthritis (RA) in China.

Methods: PubMed, Embase, Web of Science, Cochrane Library, CINAHL, and four Chinese electronic databases were searched for observational studies without language restrictions that reported the factors associated of osteoporosis from inception to February 2023. A modified Newcastle-Ottawa Scale evaluated the risk of bias. Statistical heterogeneity among the included studies was analyzed using Cochran Q and I2 tests. Begg and Egger tests were used to assess the publication bias.

Results: A total of 15 studies were finally included. The meta-analysis showed that 10 factors were grouped into three themes with statistical significance: (1) demographics theme: age ≥50 (odds ratio [OR] = 1.161; 95% CI, 1.111-1.231; p < 0.001), low body mass index (BMI) (OR = 1.248; 95% CI, 1.192-1.312; p < 0.001), female (OR = 5.174; 95% CI, 3.058-7.290; p < 0.001), and menopause (OR = 4.917; 95% CI, 1.558-15.523; I2 = 0.0%; p = 0.007); (2) RA-related factor theme: disease duration (OR = 1.083; 95% CI, 1.038-1.127; p < 0.001), and glucocorticoids (OR = 2.740; 95% CI, 2.000-3.750; p < 0.001); (3) relevant physiological indicators or scores theme: low 25(OH)D 3 (OR = 1.009; 95% CI, 1.003-1.016; p < 0.001), erythrocyte sedimentation rate (ESR) (OR = 1.489; 95% CI, 1.041-2.130; p = 0.029), high Disease Activity Score in 28 joints (DAS28) score (OR = 2.5991; 95% CI, 1.094-6.138; p < 0.001); and β-isomerized C-terminal telopeptide (β-CTx) (OR = 1.009; 95% CI, 1.003-1.016; p = 0.005).

Conclusion: Osteoporosis in patients with RA is associated with various factors. Therefore, patients with RA should be monitored in a timely manner and targeted interventions should be taken. In addition, further longitudinal studies are needed to confirm the direct link between multiple factors and osteoporosis.

背景本系统综述和荟萃分析旨在分析中国类风湿关节炎RA患者骨质疏松症的相关因素:方法:在PubMed、Embase、Web of Science、Cochrane Library、CINAHL和4个中文电子数据库中检索了从开始到2023年2月报告相关因素的无语言限制的观察性研究。采用改良的纽卡斯尔-渥太华量表评估偏倚风险。使用 Cochran's Q 和 I2 检验分析了纳入研究之间的统计异质性。Begg's 和 Egger's 检验用于评估发表偏倚:最终共纳入 15 项研究。荟萃分析表明,10 个因素被分为三个具有统计学意义的主题:(1)人口统计学主题:年龄≥50 [OR=1.161; 95% CI: (1.111,1.231); pConclusion:类风湿关节炎患者骨质疏松症与多种因素有关。因此,应及时监测类风湿关节炎患者的病情,并采取有针对性的干预措施。此外,还需要进一步的纵向研究来证实多种因素与骨质疏松症之间的直接联系。
{"title":"Associated factors of osteoporosis in Chinese patients with rheumatoid arthritis: A systematic review and meta-analysis.","authors":"Zhiming Song, Liangliang Fan, Hongyan Wang, Jun Cao, Zhifei Wen, Yanmin Tao, Xiangeng Zhang","doi":"10.1097/JCMA.0000000000001144","DOIUrl":"10.1097/JCMA.0000000000001144","url":null,"abstract":"<p><strong>Background: </strong>The aim of this systematic review and meta-analysis was to analyze the factors associated of osteoporosis in patients with rheumatoid arthritis (RA) in China.</p><p><strong>Methods: </strong>PubMed, Embase, Web of Science, Cochrane Library, CINAHL, and four Chinese electronic databases were searched for observational studies without language restrictions that reported the factors associated of osteoporosis from inception to February 2023. A modified Newcastle-Ottawa Scale evaluated the risk of bias. Statistical heterogeneity among the included studies was analyzed using Cochran Q and I2 tests. Begg and Egger tests were used to assess the publication bias.</p><p><strong>Results: </strong>A total of 15 studies were finally included. The meta-analysis showed that 10 factors were grouped into three themes with statistical significance: (1) demographics theme: age ≥50 (odds ratio [OR] = 1.161; 95% CI, 1.111-1.231; p < 0.001), low body mass index (BMI) (OR = 1.248; 95% CI, 1.192-1.312; p < 0.001), female (OR = 5.174; 95% CI, 3.058-7.290; p < 0.001), and menopause (OR = 4.917; 95% CI, 1.558-15.523; I2 = 0.0%; p = 0.007); (2) RA-related factor theme: disease duration (OR = 1.083; 95% CI, 1.038-1.127; p < 0.001), and glucocorticoids (OR = 2.740; 95% CI, 2.000-3.750; p < 0.001); (3) relevant physiological indicators or scores theme: low 25(OH)D 3 (OR = 1.009; 95% CI, 1.003-1.016; p < 0.001), erythrocyte sedimentation rate (ESR) (OR = 1.489; 95% CI, 1.041-2.130; p = 0.029), high Disease Activity Score in 28 joints (DAS28) score (OR = 2.5991; 95% CI, 1.094-6.138; p < 0.001); and β-isomerized C-terminal telopeptide (β-CTx) (OR = 1.009; 95% CI, 1.003-1.016; p = 0.005).</p><p><strong>Conclusion: </strong>Osteoporosis in patients with RA is associated with various factors. Therefore, patients with RA should be monitored in a timely manner and targeted interventions should be taken. In addition, further longitudinal studies are needed to confirm the direct link between multiple factors and osteoporosis.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"953-960"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141899263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes in ventilator-associated pneumonia patients with and without chronic obstructive pulmonary disease: A retrospective observational study. 患有和未患有慢性阻塞性肺病的呼吸机相关肺炎患者的临床疗效:一项回顾性观察研究。
Pub Date : 2024-10-01 DOI: 10.1097/JCMA.0000000000001176
Caiden Taowei Lu, Tien-Pei Fang, Ming-Szu Hung, Yi-Tsung Lin

Background: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. Critically ill patients with COPD exacerbations may require invasive mechanical ventilation (IMV). Ventilator-associated pneumonia (VAP) commonly occurs in the intensive care unit (ICU) and is usually associated with high mortality. Current studies on the relationship between COPD and VAP are limited. This work compares the etiology and clinical outcomes of VAP between patients with and without COPD in Taiwan.

Methods: This retrospective observational study was conducted at the Chiayi Chang Gung Memorial Hospital. Patients with VAP were enrolled between January 2015 and December 2019. The COPD diagnosis was based on post-bronchodilator pulmonary function tests. We compared the bacterial etiology, ICU and hospital stay length, IMV duration, and mortality.

Results: A total of 175 patients with VAP were enrolled, 44% of whom presented pre-existing COPD. The disease severity on the day of admission was similar in both groups. Microorganisms were identified in 83 (47%) patients, with Pseudomonas aeruginosa, Acinetobacter spp., and Klebsiella pneumoniae being the most common pathogens. The proportion of multi-drug resistant isolates showed no significant differences between groups. Most patients underwent antibiotic treatment before VAP onset. The length of ICU and hospital stays and IMV duration after VAP onset were similar between groups, as well as ICU mortality, in-hospital mortality and 14-day mortality.

Conclusion: Our study revealed that COPD was not associated with worse clinical outcomes in patients with VAP. No significant differences in bacterial etiology were observed between the two groups.

背景:慢性阻塞性肺病(COPD慢性阻塞性肺病(COPD)是全球第三大死亡原因。慢性阻塞性肺疾病加重的重症患者可能需要进行有创机械通气(IMV)。呼吸机相关性肺炎(VAP)通常发生在重症监护病房(ICU),死亡率通常很高。目前关于慢性阻塞性肺病与 VAP 关系的研究还很有限。本研究比较了台湾慢性阻塞性肺病患者和非慢性阻塞性肺病患者 VAP 的病因和临床结果:这项回顾性观察研究在嘉义长庚纪念医院进行。VAP 患者于 2015 年 1 月至 2019 年 12 月间入组。慢性阻塞性肺病的诊断基于支气管扩张剂后肺功能测试。我们比较了细菌病因、ICU和住院时间、IMV持续时间和死亡率:共有 175 名 VAP 患者入选,其中 44% 的患者在入院前已患有慢性阻塞性肺病。两组患者入院当天的病情严重程度相似。在 83 例(47%)患者中发现了微生物,铜绿假单胞菌、醋杆菌属和肺炎克雷伯菌是最常见的病原体。耐多药分离菌的比例在各组之间无明显差异。大多数患者在 VAP 发病前接受了抗生素治疗。各组间的重症监护室和住院时间、VAP发生后的IMV持续时间以及重症监护室死亡率、院内死亡率和14天死亡率相似:我们的研究表明,慢性阻塞性肺病与VAP患者更差的临床预后无关。结论:我们的研究表明,慢性阻塞性肺病与 VAP 患者更差的临床预后无关,两组患者的细菌病因也无明显差异。
{"title":"Clinical outcomes in ventilator-associated pneumonia patients with and without chronic obstructive pulmonary disease: A retrospective observational study.","authors":"Caiden Taowei Lu, Tien-Pei Fang, Ming-Szu Hung, Yi-Tsung Lin","doi":"10.1097/JCMA.0000000000001176","DOIUrl":"https://doi.org/10.1097/JCMA.0000000000001176","url":null,"abstract":"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. Critically ill patients with COPD exacerbations may require invasive mechanical ventilation (IMV). Ventilator-associated pneumonia (VAP) commonly occurs in the intensive care unit (ICU) and is usually associated with high mortality. Current studies on the relationship between COPD and VAP are limited. This work compares the etiology and clinical outcomes of VAP between patients with and without COPD in Taiwan.</p><p><strong>Methods: </strong>This retrospective observational study was conducted at the Chiayi Chang Gung Memorial Hospital. Patients with VAP were enrolled between January 2015 and December 2019. The COPD diagnosis was based on post-bronchodilator pulmonary function tests. We compared the bacterial etiology, ICU and hospital stay length, IMV duration, and mortality.</p><p><strong>Results: </strong>A total of 175 patients with VAP were enrolled, 44% of whom presented pre-existing COPD. The disease severity on the day of admission was similar in both groups. Microorganisms were identified in 83 (47%) patients, with Pseudomonas aeruginosa, Acinetobacter spp., and Klebsiella pneumoniae being the most common pathogens. The proportion of multi-drug resistant isolates showed no significant differences between groups. Most patients underwent antibiotic treatment before VAP onset. The length of ICU and hospital stays and IMV duration after VAP onset were similar between groups, as well as ICU mortality, in-hospital mortality and 14-day mortality.</p><p><strong>Conclusion: </strong>Our study revealed that COPD was not associated with worse clinical outcomes in patients with VAP. No significant differences in bacterial etiology were observed between the two groups.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of low-dose ketamine on electroencephalographic spectrum during gynecology surgery under desflurane anesthesia. 地氟醚麻醉下小剂量氯胺酮对妇科手术中脑电频谱的影响
Pub Date : 2024-10-01 Epub Date: 2024-08-07 DOI: 10.1097/JCMA.0000000000001142
Yu-Pin Huang, Shih-Pin Lin, Huann-Cheng Horng, Wen-Kuei Chang, Cheng-Ming Tsao

Background: The perioperative administration of low-dose ketamine has shown potential in postoperative pain management, opioid sparing, and enhancing pain control. This study aimed to investigate the impact of low-dose ketamine on processed electroencephalography (EEG) signals during anesthesia.

Methods: Forty patients with American Society of Anesthesiologists physical status I-II undergoing elective gynecological surgery were enrolled. EEG monitoring was initiated upon induction of anesthesia. Anesthesia was maintained with desflurane and alfentanil immediately after induction. Fifteen minutes after induction, the ketamine group received a 0.3 mg/kg bolus followed by 0.05 mg/kg/h infusion until completion of surgery. The control group received equivalent saline. Postoperative assessments included pain score (visual analog scale), morphine usage, and quality of recovery.

Results: The ketamine group had significantly higher Patient State Index (PSi) values at 10, 20, and 30 minutes after ketamine administration compared to the controls. Ketamine administration led to significant alterations in EEG patterns, including reduced relative power in delta and theta frequency bands, and increased relative power in beta and gamma frequency bands at 10 minutes post-administration. Relative power in the alpha frequency band significantly decreased at 10, 20, and 30 minutes post-administration. However, there were no differences in intraoperative alfentanil consumption, postoperative morphine usage, and pain scores between the two groups.

Conclusion: Low-dose ketamine administration during desflurane anesthesia led to notable changes in EEG patterns and PSi values. These findings provide valuable insights into the impact of ketamine on brain activity, and offer essential information for clinical anesthesiologists.

背景:围手术期使用低剂量氯胺酮在术后疼痛管理、阿片类药物替代和加强疼痛控制方面具有潜力。本研究旨在探讨低剂量氯胺酮对麻醉期间脑电图(EEG)信号处理的影响:方法:40 名美国麻醉医师协会身体状况为 I-II 级的患者接受择期妇科手术。麻醉诱导后即开始监测脑电图。诱导后立即使用地氟醚和阿芬太尼维持麻醉。诱导15分钟后,氯胺酮组接受0.3毫克/千克的静脉注射,然后以0.05毫克/千克/小时的速度输注,直至手术结束。对照组接受等量生理盐水。术后评估包括疼痛评分(视觉模拟量表)、吗啡用量和恢复质量:结果:与对照组相比,氯胺酮组在给药后 10 分钟、20 分钟和 30 分钟的患者状态指数(PSi)值明显更高。氯胺酮用药后 10 分钟,脑电图模式发生了显著变化,包括 delta 和 theta 频段的相对功率降低,而 beta 和 gamma 频段的相对功率增加。给药后 10、20 和 30 分钟,α 频段的相对功率显著下降。不过,两组患者在术中阿芬太尼用量、术后吗啡用量和疼痛评分方面没有差异:结论:在去氟烷麻醉期间给予小剂量氯胺酮会导致脑电图模式和 PSi 值发生显著变化。这些发现为氯胺酮对大脑活动的影响提供了宝贵的见解,并为临床麻醉师提供了重要信息。
{"title":"The effect of low-dose ketamine on electroencephalographic spectrum during gynecology surgery under desflurane anesthesia.","authors":"Yu-Pin Huang, Shih-Pin Lin, Huann-Cheng Horng, Wen-Kuei Chang, Cheng-Ming Tsao","doi":"10.1097/JCMA.0000000000001142","DOIUrl":"10.1097/JCMA.0000000000001142","url":null,"abstract":"<p><strong>Background: </strong>The perioperative administration of low-dose ketamine has shown potential in postoperative pain management, opioid sparing, and enhancing pain control. This study aimed to investigate the impact of low-dose ketamine on processed electroencephalography (EEG) signals during anesthesia.</p><p><strong>Methods: </strong>Forty patients with American Society of Anesthesiologists physical status I-II undergoing elective gynecological surgery were enrolled. EEG monitoring was initiated upon induction of anesthesia. Anesthesia was maintained with desflurane and alfentanil immediately after induction. Fifteen minutes after induction, the ketamine group received a 0.3 mg/kg bolus followed by 0.05 mg/kg/h infusion until completion of surgery. The control group received equivalent saline. Postoperative assessments included pain score (visual analog scale), morphine usage, and quality of recovery.</p><p><strong>Results: </strong>The ketamine group had significantly higher Patient State Index (PSi) values at 10, 20, and 30 minutes after ketamine administration compared to the controls. Ketamine administration led to significant alterations in EEG patterns, including reduced relative power in delta and theta frequency bands, and increased relative power in beta and gamma frequency bands at 10 minutes post-administration. Relative power in the alpha frequency band significantly decreased at 10, 20, and 30 minutes post-administration. However, there were no differences in intraoperative alfentanil consumption, postoperative morphine usage, and pain scores between the two groups.</p><p><strong>Conclusion: </strong>Low-dose ketamine administration during desflurane anesthesia led to notable changes in EEG patterns and PSi values. These findings provide valuable insights into the impact of ketamine on brain activity, and offer essential information for clinical anesthesiologists.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"933-939"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141899264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The neuropsychological impacts of COVID-19 in non-hospitalized patients with long COVID and brain fog. COVID-19 对长期 COVID 和脑雾的非住院患者的神经心理学影响。
Pub Date : 2024-10-01 DOI: 10.1097/JCMA.0000000000001175
Yu-Chen Chuang, Yu-Hsiang Cheng, Meng-Ju Tsai, Yi-Jiun Lu, Jong-Ling Fuh

Background: Coronavirus disease 2019 (COVID-19) causes persistent symptoms, including brain fog. Based on limited research on the long-term consequences of mild COVID-19, which has yielded inconsistent results, we investigated which cognitive functions were most affected by COVID-19 in non-hospitalized Asian patients with long-term COVID and subjective cognitive complaints.

Methods: Fifty-five non-hospitalized patients with long COVID and brain fog (24 males and 31 females, mean age: 45.6 ± 14.6 years, mean duration of education: 14.4 ± 3.0 years) were recruited. Neuropsychological assessments included screening tests for overall cognition, and comprehensive tests for memory, executive function, processing speed, and subjective emotional and disease symptoms. Cognitive test scores were converted into Z-scores. Moreover, principal component analysis (PCA) was employed to define cognitive domains across subtest scores.

Results: Comprehensive assessments revealed cognitive impairment in 69.1% of patients (<1.5 standard deviation in at least one test). The processing speed (27.3%), memory recall (21.8%), memory learning (20.0%), and inhibitory control (18.2%) were the most affected areas. Self-reported anxiety and depression were observed in 35% and 33% of patients, respectively. Furthermore, the degree of self-anxiety can be used to predict learning performance.

Conclusion: Nearly 70% of patients with subjective cognitive complaints and long COVID had objective cognitive impairments. A comprehensive evaluation is essential for patients with long COVID and brain fog, including those with mild symptoms.

背景:冠状病毒病 2019(COVID-19)会导致包括脑雾在内的持续性症状。基于对轻度COVID-19长期后果的研究有限,且研究结果不一致,我们在非住院的亚洲长期COVID和主观认知症状患者中调查了COVID-19对哪些认知功能的影响最大:方法:55 名患有长期 COVID 和脑雾的非住院患者(男性 24 人,女性 31 人,平均年龄:45.6 ± 14.6 岁,平均受教育时间:14.4 ± 3.0 年,平均年龄:45.6 ± 14.6 岁,平均受教育时间:14.4 ± 3.0 年平均年龄:45.6 ± 14.6 岁,平均受教育时间:14.4 ± 3.0 年)。神经心理学评估包括总体认知筛选测试,以及记忆、执行功能、处理速度、主观情绪和疾病症状综合测试。认知测试得分被转换成 Z 分数。此外,还采用了主成分分析法(PCA)来界定不同子测试得分的认知领域:结果:综合评估显示,69.1% 的患者存在认知障碍(结论:近 70% 有主观症状的患者存在认知障碍):近 70% 有主观认知症状且 COVID 较长的患者存在客观认知障碍。对长期 COVID 和脑雾患者(包括症状轻微者)进行全面评估至关重要。
{"title":"The neuropsychological impacts of COVID-19 in non-hospitalized patients with long COVID and brain fog.","authors":"Yu-Chen Chuang, Yu-Hsiang Cheng, Meng-Ju Tsai, Yi-Jiun Lu, Jong-Ling Fuh","doi":"10.1097/JCMA.0000000000001175","DOIUrl":"https://doi.org/10.1097/JCMA.0000000000001175","url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease 2019 (COVID-19) causes persistent symptoms, including brain fog. Based on limited research on the long-term consequences of mild COVID-19, which has yielded inconsistent results, we investigated which cognitive functions were most affected by COVID-19 in non-hospitalized Asian patients with long-term COVID and subjective cognitive complaints.</p><p><strong>Methods: </strong>Fifty-five non-hospitalized patients with long COVID and brain fog (24 males and 31 females, mean age: 45.6 ± 14.6 years, mean duration of education: 14.4 ± 3.0 years) were recruited. Neuropsychological assessments included screening tests for overall cognition, and comprehensive tests for memory, executive function, processing speed, and subjective emotional and disease symptoms. Cognitive test scores were converted into Z-scores. Moreover, principal component analysis (PCA) was employed to define cognitive domains across subtest scores.</p><p><strong>Results: </strong>Comprehensive assessments revealed cognitive impairment in 69.1% of patients (<1.5 standard deviation in at least one test). The processing speed (27.3%), memory recall (21.8%), memory learning (20.0%), and inhibitory control (18.2%) were the most affected areas. Self-reported anxiety and depression were observed in 35% and 33% of patients, respectively. Furthermore, the degree of self-anxiety can be used to predict learning performance.</p><p><strong>Conclusion: </strong>Nearly 70% of patients with subjective cognitive complaints and long COVID had objective cognitive impairments. A comprehensive evaluation is essential for patients with long COVID and brain fog, including those with mild symptoms.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antihyperlipidemic drugs mitigate the elevated incidence of peptic ulcer disease caused by hyperlipidemia: A cohort study. 抗高脂血症药物可减轻高脂血症导致的消化性溃疡发病率升高:一项队列研究。
Pub Date : 2024-10-01 Epub Date: 2024-08-09 DOI: 10.1097/JCMA.0000000000001145
Pei-Hsien Chen, Chiu-Lin Tsai, Yow-Wen Hsieh, Der-Yang Cho, Fuu-Jen Tsai, Cheng-Li Lin, Hsien-Yin Liao

Background: Several risk factors for peptic ulcer disease (PUD) have been identified; however, the recurrence rate of PUD remains high even with standard ulcer treatments. High cholesterol levels have been proposed as a risk factor for PUD, but clinical evidence remains limited. Therefore, this database study investigated whether hyperlipidemia increases PUD risk and whether antihyperlipidemic drugs reduce this risk.

Methods: A long-term cohort design was adopted, and Taiwan's National Health Insurance Research Database was used to enroll patients diagnosed with hyperlipidemia between 2000 and 2016. Patients without hyperlipidemia were randomly matched based on variables such as age and gender to establish a comparison cohort at a 1:1 ratio. Another cohort study was conducted to determine whether antihyperlipidemic drugs or red yeast rice prescriptions can reduce the incidence of PUD in patients with hyperlipidemia.

Results: The overall incidence of PUD was 1.48 times higher in the hyperlipidemia cohort (203,235 patients) than in the nonhyperlipidemia cohort (adjusted hazard ratio, 1.48; 95% CI, 1.46-1.50; p < 0.001). Among the patients with hyperlipidemia, those who used antihyperlipidemic drugs with or without red yeast rice prescriptions exhibited a lower risk of developing PUD relative to those who did not use them; the adjusted hazard ratios were 0.33 (95% CI, 0.21-0.52) and 0.81 (95% CI, 0.78-0.84), respectively. When the cumulative exposure to antihyperlipidemic drugs and red yeast rice prescriptions increased, the risk of developing PUD showed a decreasing trend, which was statistically significant for antihyperlipidemic drugs but not for red yeast rice.

Conclusion: Hyperlipidemia is associated with a higher risk of PUD, which can be reduced through the administration of antihyperlipidemic drugs with or without red yeast rice prescriptions.

背景:消化性溃疡病(PUD)的几个风险因素已被确定;然而,即使采用标准的溃疡治疗方法,PUD 的复发率仍然很高。高胆固醇水平被认为是 PUD 的一个风险因素,但临床证据仍然有限。因此,本数据库研究探讨了高脂血症是否会增加 PUD 风险,以及抗高脂血症药物是否会降低这一风险:方法:采用长期队列设计,利用台湾国民健康保险研究数据库,纳入2000年至2016年间被诊断为高脂血症的患者。根据年龄和性别等变量随机匹配无高脂血症的患者,以 1:1 的比例建立对比队列。另一项队列研究旨在确定抗高脂血症药物或红麴处方(LipoCol Forte®)能否降低高脂血症患者的 PUD 发病率:高脂血症队列(203 235 名患者)的 PUD 总发病率是非高脂血症队列的 1.48 倍(调整后危险比为 1.48;95% CI 为 1.46-1.50;P < 0.001)。在高脂血症患者中,使用或未使用红曲米处方的抗高脂血症药物的患者与未使用这些药物的患者相比,患 PUD 的风险较低;调整后的危险比分别为 0.33(95% CI,0.21-0.52)和 0.81(95% CI,0.78-0.84)。当抗血脂药物和红曲米处方的累积暴露量增加时,罹患 PUD 的风险呈下降趋势,抗血脂药物的下降趋势具有统计学意义,而红曲米的下降趋势不具有统计学意义:结论:高脂血症与罹患 PUD 的较高风险有关,无论是否服用红曲米处方,都可以通过服用降脂药来降低罹患 PUD 的风险。
{"title":"Antihyperlipidemic drugs mitigate the elevated incidence of peptic ulcer disease caused by hyperlipidemia: A cohort study.","authors":"Pei-Hsien Chen, Chiu-Lin Tsai, Yow-Wen Hsieh, Der-Yang Cho, Fuu-Jen Tsai, Cheng-Li Lin, Hsien-Yin Liao","doi":"10.1097/JCMA.0000000000001145","DOIUrl":"10.1097/JCMA.0000000000001145","url":null,"abstract":"<p><strong>Background: </strong>Several risk factors for peptic ulcer disease (PUD) have been identified; however, the recurrence rate of PUD remains high even with standard ulcer treatments. High cholesterol levels have been proposed as a risk factor for PUD, but clinical evidence remains limited. Therefore, this database study investigated whether hyperlipidemia increases PUD risk and whether antihyperlipidemic drugs reduce this risk.</p><p><strong>Methods: </strong>A long-term cohort design was adopted, and Taiwan's National Health Insurance Research Database was used to enroll patients diagnosed with hyperlipidemia between 2000 and 2016. Patients without hyperlipidemia were randomly matched based on variables such as age and gender to establish a comparison cohort at a 1:1 ratio. Another cohort study was conducted to determine whether antihyperlipidemic drugs or red yeast rice prescriptions can reduce the incidence of PUD in patients with hyperlipidemia.</p><p><strong>Results: </strong>The overall incidence of PUD was 1.48 times higher in the hyperlipidemia cohort (203,235 patients) than in the nonhyperlipidemia cohort (adjusted hazard ratio, 1.48; 95% CI, 1.46-1.50; p < 0.001). Among the patients with hyperlipidemia, those who used antihyperlipidemic drugs with or without red yeast rice prescriptions exhibited a lower risk of developing PUD relative to those who did not use them; the adjusted hazard ratios were 0.33 (95% CI, 0.21-0.52) and 0.81 (95% CI, 0.78-0.84), respectively. When the cumulative exposure to antihyperlipidemic drugs and red yeast rice prescriptions increased, the risk of developing PUD showed a decreasing trend, which was statistically significant for antihyperlipidemic drugs but not for red yeast rice.</p><p><strong>Conclusion: </strong>Hyperlipidemia is associated with a higher risk of PUD, which can be reduced through the administration of antihyperlipidemic drugs with or without red yeast rice prescriptions.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"961-968"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Chinese Medical Association : JCMA
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1